January 22, 2026
Egg Donation Medications Explained for Donors
Egg donation enables over 5,000 patients to become parents annually. The process involves self-administered fertility injections to stimulate multiple egg follicles. Potential risks include ovarian hyperstimulation syndrome (OHSS), which affects less than 1 in 200 cycles.
Key Takeaways
Self-Administered Fertility Injections for Egg Stimulation
Donors receive injectable medications to stimulate all ovarian follicles instead of the body’s natural selection of one egg. Training sessions and video tutorials are provided to ensure confidence in self-administering injections.
Comprehensive Injection Training for Egg Donors
SGF offers hands-on injection training during donor orientation, including mixing medications and using needles. Nurses provide additional support to address any discomfort or uncertainty during the process.
Ovarian Hyperstimulation Syndrome (OHSS) Risks and Prevalence
OHSS, characterized by swollen ovaries and fluid accumulation, occurs in less than 1% of cycles. Severe cases are rare, and SGF monitors donors closely to mitigate complications.
No Evidence of Fertility Impact from Egg Donation
Research confirms egg donation does not affect a donor’s future fertility. SGF offers free physician consultations to address concerns about reproductive health post-donation.
Long-Term Cancer Risk: 35 Years of IVF Data
Over 35 million IVF cycles globally show no increased cancer risk for donors. SGF cites extensive data to reassure donors about the safety of fertility treatments.
Source: Read full article